In Vitro Considerations to Support Bioequivalence of Locally Acting Drugs in Dry Powder Inhalers for Lung Diseases

Dry powder inhalers (DPIs) are used to deliver locally acting drugs (e.g., bronchodilators and corticosteroids) for treatment of lung diseases such as asthma and chronic obstructive pulmonary disease (COPD). Demonstrating bioequivalence (BE) for DPI products is challenging, primarily due to an incom...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Lee, Sau Lawrence, Adams, Wallace P., Li, Bing V., Conner, Dale P., Chowdhury, Badrul A., Yu, Lawrence X.
Формат: Artigo
Язык:Inglês
Опубликовано: Springer US 2009
Предметы:
Regulatory Note
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2758114/
https://ncbi.nlm.nih.gov/pubmed/19495991
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1208/s12248-009-9121-4
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы